Research Interests

The development of a pluripotent stem cell model to study the specification and development of human trophoblast: In 2002, my group was looking for a cellular model in which to examine transcription factors that were responsible for controlling the expression of signature gene products of the placenta, e.g. CG subunits in human and IFNT in ruminant species. Our hypothesis was the same transcription factors might also be involved in specifying trophoblast. Our work made use of an observation from Jamie Thomson?s that BMP4 caused human embryonic stem cells to differentiate along several lineages including trophoblast. In our initial work with these cells we demonstrated that the spontaneous differentiation that occurs when culturing ESC can be minimized by using a low O2 atmosphere. Also, differentiation to trophoblast could be maximized if FGF2 was removed from the culture medium. The ESC in absence of FGF2 and presence of BMP4 differentiate to both extravillous trophoblast and syncytiotrophoblast. The laboratory is currently using this model to examine the differentiation of induced pluripotent stem cells derived from primary mesenchymal cells from umbilical cords of babies born to mothers who experienced severe, early-onset preeclampsia. The goal is to re-create placental cells from the earlier pregnancy and determine whether there are abnormalities associated with the disease. These cells are also being studied to understand the susceptibility of the primitive placenta of the implanting human conceptus to virus, including the Zika virus and COVID19.

Membership Type


Election Year


Primary Section

Section 61: Animal, Nutritional, and Applied Microbial Sciences

Secondary Section

Section 62: Plant, Soil, and Microbial Sciences